Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The genetic spectrum of LRRK2 variants in Parkinson's disease: findings from a large Chinese cohort.

NPJ Parkinson's disease·2026
Same author

Large-scale profiling of blood microbial signatures in patients with Parkinson's disease and its association with disease progression: a cross-sectional study.

EBioMedicine·2026
Same author

Shared genetic architecture between sleep traits and cardiometabolic diseases.

EBioMedicine·2026
Same author

Gut microbiota modulation via repeated donor fecal transplantation improves motor and gastrointestinal symptoms in drug-naïve Parkinson's disease: a randomized phase 2 trial.

Signal transduction and targeted therapy·2026
Same author

Short tandem repeat expansions in patients with neurodegenerative dementia.

EBioMedicine·2026
Same author

Aging of the Blood-Brain Barrier and Altered Permeability to Peripheral Immune Cells: Implications for Central Nervous System Disorders.

Aging and disease·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Sizhe Zhang1, Bin Jiao1, Yan Zeng1

  • 1Xiangya Hospital, Central South University, Changsha, Hunan, China.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

生物标志物水平,如化 (p-tau) 和状纤维酸蛋白 (GFAP) 在神经内核包容性疾病 (NIID) 和其症状前阶段 (preNIID) 中升高. 这些生物标志物显示出早期NIID检测的潜力,但难以将NIID与阿尔茨海默病 (AD) 区分开来.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物发现发现
  • 神经退行性疾病 神经退行性疾病

背景情况:

  • 神经内核包容性疾病 (NIID) 是NOTCH2NLC中的GGC重复扩张疾病,导致认知障碍和内核包容性.
  • 关于NIID和症状前NIID (preNIID) 的生物标志物改变的研究有限.
  • 在NIID和阿尔茨海默病 (AD) 生物标志物之间进行直接比较很少.

研究的目的:

  • 综合分析NIID患者和NIID前个体的血生物标志物变化.
  • 为了比较NIID,AD和健康对照 (HCs) 之间的生物标志物概况.
  • 评估NIID和NIID前检测生物标志物的诊断潜力.

主要方法:

  • 分析了两个队列:第一队列 (344名参与者:87名NIID,147名AD,110名HC) 和第二队列 (52名参与者:26名NIID前,26名HC).
  • 测量了八种血生物标志物:粉样β (Aβ) 40,Aβ42,神经丝光 (NfL),α-synuclein (α-syn),酸化陶蛋白181 (p-tau181),p-tau217,p-tau231,以及状纤维酸性蛋白 (GFAP).
  • 进行了神经心理测试和MRI.

主要成果:

  • 与HC相比,NIID中的NfL,α-syn,p-tau181,p-tau217,p-tau231和GFAP都在NIID中升高.
  • 在NIID和AD之间,α-syn,p-tau181,p-tau217和p-tau231水平相似,而NIID中NfL较高,GFAP较低.
  • p-tau217在NIID与HC之间表现出强大的诊断性能 (AUC0.814),而p-tau物种和GFAP显示出在NIID前检测的潜力 (AUC~0.850).
  • 在NIID前的个体中观察到高的p-tau物种和GFAP.
  • 包括p-tau217在内的酸化 (p-tau) 种类无法可靠地区分NIID和AD.

结论:

  • 血p-tau水平,特别是p-tau217,为NIID病理生理学提供了新的见解.
  • 在NIID前的p-tau物种和GFAP的早期变化突出了它们作为NIID早期诊断生物标志物的潜力.
  • p-tau物种在区分NIID和AD方面并不有效,这表明有不同的潜在病理或生物标志物限制.